Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Cognos Therapeutics, Inc. to Become Publicly Listed on Nasdaq via Business Combination with Nocturne Acquisition Corporation
-
Safe & Green (SGBX) Announces Intended Spin-off of Safe and Green Development Corporation
-
Horizon Space Acquisition I Corp. Announces Closing of $69 Million Initial Public Offering
-
Safe & Green Holding Corp. Announces Intended Spin-off of Safe and Green Development Corporation
-
Bio-key International (BKYI) Announces $2.2M in Funding via Promissory Note Financing
-
BIO-key Secures $2.2M in Funding via Promissory Note Financing
-
Today's most important initiations
-
Maxim Group starts MediWound Ltd (MDWD) at Buy on advanced pipeline in wound care
-
Horizon Space Acquisition I Corp. Announces Pricing of $60 Million Initial Public Offering
-
Viking Therapeutic (VKTX) PT Raised to $15 at Maxim Group
-
Harrow Secures Capital to Close Recently Announced Acquisition
-
Harrow Health (HROW) to offer $100 million of senior notes due in 2027
-
Harrow Announces Proposed Offering of $100 Million of Senior Notes Due 2027 and “BB” Rating from Egan-Jones
-
ContraFect (CFRX) Announces Pricing of $7.0 Million Registered Direct Offering and Concurrent Private Placement
-
ContraFect Announces Pricing of $7.0 Million Registered Direct Offering and Concurrent Private Placement
-
Blue Water Vaccines Announces Institutional Research Coverage by Two Notable Healthcare-Focused Wall Street Banks, Receives “Buy” Rating From Both
-
TOP Ships Announces Closing of $13.5 Million Public Offering
-
Saratoga Investment Corp. Prices Public Offering of $52.5 Million 8.125% Notes Due 2027
-
Saratoga Investment Corp. Prices Public Offering of $52.5 Million 8.125% Notes Due 2027
-
Saratoga Investment Corp. Announces Offering of Notes and BBB+ Investment Grade Rating from Egan-Jones Ratings Company
-
Saratoga Investment Corp. Announces Offering of Notes and BBB+ Investment Grade Rating from Egan-Jones Ratings Company
-
Top Ships (TOPS) Prices 6.75M Share Offering at $2/Unit
-
TOP Ships Announces Pricing of $13.5 Million Public Offering
-
AN ARTFUL ALLIANCE: NINA MAGON TRANSFORMS COSENTINO MIAMI CITY CENTER INTO AN IMMERSIVE INSTALLATION FOR MIAMI ART WEEK
-
AN ARTFUL ALLIANCE: NINA MAGON TRANSFORMS COSENTINO MIAMI CITY CENTER INTO AN IMMERSIVE INSTALLATION FOR MIAMI ART WEEK
-
WiSA Technologies Announces Closing of Previously Announced $7.6 Million Public Offering
-
WiSA Technologies (WISA) Prices 50.4M Units at $0.14 Each
-
WiSA Technologies Announces Pricing of $7.6 Million Public Offering
-
scPharmaceuticals (SCPH) Prices 6.62M Share Offering at $5.25/sh
-
scPharmaceuticals Announces Pricing of $50 Million Public Offering
-
Kraig Biocraft Laboratories Completes Closeout of $8 Million Financing, Extinguishing All Convertible Debentures with Yorkville Advisors
-
Maxim Group: Society Pass (Nasdaq: SOPA) Despite Challenging Global Macro Environment, Reiterates Positive Outlook on SOPA Based on Strong Revenue Generation and Compelling Valuation
-
Maxim Group: Society Pass (Nasdaq: SOPA) - Despite Challenging Global Macro Environment, Reiterates Positive Outlook on SOPA Based on Strong Revenue Generation and Compelling Valuation
-
Maxim Group: Society Pass (Nasdaq: SOPA) - Despite Challenging Global Macro Environment, Reiterates Positive Outlook on SOPA Based on Strong Revenue Generation and Compelling Valuation
-
ReShape Lifesciences Inc. (RSLS) Announces $750,000 Registered Direct Offering
-
ReShape Lifesciences Announces $750,000 Registered Direct Offering
-
ReShape Lifesciences Announces $750,000 Registered Direct Offering
-
Trxade Group Inc. (MEDS) PT Lowered to $2.50 at Maxim Group
-
Cellectar Biosciences (CLRB) PT Lowered to $7 at Maxim Group
-
Atlis Motor Vehicles, Inc. Closes Initial $10.0 Million Tranche of $30.0 Million Private Placement
-
Atlis Motor Vehicles, Inc. Closes Initial $10.0 Million Tranche of $30.0 Million Private Placement
-
Quanergy Announces Closing of $16.7 Million Upsized Underwritten Public Offering
-
Otter Tail Corporation (OTTR) PT Lowered to $75 at Maxim Group
-
SolarJuice (SJA) Announces Proposed IPO
-
Quanergy Systems (QNGY) Prices Upsized 9.8M Unit Offering at $1.70/unit
-
Quanergy Announces Pricing of $16.7 Million Upsized Underwritten Public Offering
-
SeaStar Medical Completes Business Combination with LMF Acquisition Opportunities
-
Kalera Public (KAL) Prices 68M Share Offering at $0.13/sh
-
Kalera Public Limited Company Announces Pricing of $8.84 Million Public Offering
-
Kalera Public Limited Company Announces Pricing of $8.84 Million Public Offering

